BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8221366)

  • 41. The efficacy of the dicon screening field to detect eyes with glaucomatous field loss by Humphrey threshold testing.
    Huang AS; Smith SD; Quigley HA
    J Glaucoma; 1998 Jun; 7(3):158-64. PubMed ID: 9627854
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relationship between second-generation frequency doubling technology and standard automated perimetry in patients with glaucoma.
    Zarkovic A; Mora J; McKelvie J; Gamble G
    Clin Exp Ophthalmol; 2007 Dec; 35(9):808-11. PubMed ID: 18173407
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The usefulness of frequency doubling technology perimetry in glaucoma screening in health-check program].
    Kusaba K; Kawanami M; Ban Y
    Nippon Ganka Gakkai Zasshi; 2004 Sep; 108(9):554-9. PubMed ID: 15506489
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The screening of the central visual field.
    Krieglstein GK; Andrae K
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1975; 193(2):145-52. PubMed ID: 1078956
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Probing glaucoma visual damage by rarebit perimetry.
    Brusini P; Salvetat ML; Parisi L; Zeppieri M
    Br J Ophthalmol; 2005 Feb; 89(2):180-4. PubMed ID: 15665349
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oculokinetic perimetry for the assessment of visual fields.
    Clark BJ; Timms C; Franks WA
    Arch Dis Child; 1990 Apr; 65(4):432-4. PubMed ID: 2346336
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Static versus kinetic testing in the nasal peripheral field in patients with glaucoma.
    Stewart WC
    Acta Ophthalmol (Copenh); 1992 Feb; 70(1):79-84. PubMed ID: 1557979
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Usefulness of gaze tracking during perimetry in glaucomatous eyes].
    Kunimatsu S; Suzuki Y; Shirato S; Araie M
    Nippon Ganka Gakkai Zasshi; 1999 Oct; 103(10):748-53. PubMed ID: 10554550
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Peripheral visual field testing in glaucoma by automated kinetic perimetry with the Humphrey Field Analyzer.
    Ballon BJ; Echelman DA; Shields MB; Ollie AR
    Arch Ophthalmol; 1992 Dec; 110(12):1730-2. PubMed ID: 1463413
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A new index to monitor central visual field progression in glaucoma.
    de Moraes CG; Furlanetto RL; Ritch R; Liebmann JM
    Ophthalmology; 2014 Aug; 121(8):1531-8. PubMed ID: 24726202
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Performance of frequency-doubling technology perimetry in a population-based prevalence survey of glaucoma: the Tajimi study.
    Iwase A; Tomidokoro A; Araie M; Shirato S; Shimizu H; Kitazawa Y;
    Ophthalmology; 2007 Jan; 114(1):27-32. PubMed ID: 17070580
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Frequency doubling technology perimetry in open-angle glaucoma eyes with hemifield visual field damage: comparison of high-tension and normal-tension groups.
    Murata H; Tomidokoro A; Matsuo H; Tomita G; Araie M
    J Glaucoma; 2007 Jan; 16(1):9-13. PubMed ID: 17224743
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of visual field sensitivities between the Medmont automated perimeter and the Humphrey field analyser.
    Landers J; Sharma A; Goldberg I; Graham SL
    Clin Exp Ophthalmol; 2010 Apr; 38(3):273-6. PubMed ID: 20447123
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of Damato campimetry and Humphrey automated perimetry results in a clinical population.
    Rowe FJ; Sueke H; Gawley SD
    Br J Ophthalmol; 2010 Jun; 94(6):757-62. PubMed ID: 20447958
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Frequency-doubling threshold perimetry in predicting glaucoma in a population-based study: The Beijing Eye Study.
    Wang YX; Xu L; Zhang RX; Jonas JB
    Arch Ophthalmol; 2007 Oct; 125(10):1402-6. PubMed ID: 17923550
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Correlation of frequency-doubling perimetry with retinal nerve fiber layer thickness and optic disc size in ocular hypertensives and glaucoma suspects.
    Kaushik S; Pandav SS; Ichhpujani P; Gupta A
    J Glaucoma; 2011 Aug; 20(6):366-70. PubMed ID: 20717056
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of the high specificity Screening Program (C-20-1) of the Frequency Doubling Technology (FDT) perimeter in clinical practice.
    North RV; Jones AL; Hunter E; Morgan JE; Wild JM
    Eye (Lond); 2006 Jun; 20(6):681-7. PubMed ID: 15999135
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Factors that influence the prevalence of positive catch trials in glaucoma patients.
    Reynolds M; Stewart WC; Sutherland S
    Graefes Arch Clin Exp Ophthalmol; 1990; 228(4):338-41. PubMed ID: 2401419
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Duration of automated suprathreshold vs quantitative threshold field examination. Impact of age and ocular status.
    Kosoko O; Sommer A; Auer C
    Arch Ophthalmol; 1986 Mar; 104(3):398-401. PubMed ID: 3954641
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term follow-up of baseline learning and fatigue effects in the automated perimetry of glaucoma and ocular hypertensive patients.
    Wild JM; Searle AE; Dengler-Harles M; O'Neill EC
    Acta Ophthalmol (Copenh); 1991 Apr; 69(2):210-6. PubMed ID: 1872140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.